Zyla Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZYLA
ZYLA has five approved drugs.
There are nine US patents protecting ZYLA drugs.
There are fifty-five patent family members on ZYLA drugs in twenty-three countries and one supplementary protection certificate in one country.
Summary for Zyla
| International Patents: | 55 |
| US Patents: | 9 |
| Tradenames: | 5 |
| Ingredients: | 4 |
| NDAs: | 5 |
Drugs and US Patents for Zyla
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zyla | ARYMO ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 208603-001 | Jan 9, 2017 | DISCN | Yes | No | 9,549,899 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Zyla | ARYMO ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 208603-003 | Jan 9, 2017 | DISCN | Yes | No | 9,549,899 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Zyla | ZORVOLEX | diclofenac | CAPSULE;ORAL | 204592-001 | Oct 18, 2013 | DISCN | Yes | No | 9,180,096 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Zyla | ZORVOLEX | diclofenac | CAPSULE;ORAL | 204592-001 | Oct 18, 2013 | DISCN | Yes | No | 8,679,544 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Zyla
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Zyla | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-002 | Jun 17, 2011 | 8,637,540 | ⤷ Start Trial |
| Zyla | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-001 | Jun 17, 2011 | 8,637,540 | ⤷ Start Trial |
| Zyla | INDOCIN SR | indomethacin | CAPSULE, EXTENDED RELEASE;ORAL | 018185-001 | Feb 23, 1982 | 4,173,626 | ⤷ Start Trial |
| Zyla | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-002 | Jun 17, 2011 | 9,492,443 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ZYLA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsules | 18 mg and 35 mg | ➤ Subscribe | 2014-06-06 |
| ➤ Subscribe | Extended-release Tablets | 15 mg, 30 mg and 60 mg | ➤ Subscribe | 2017-12-29 |
International Patents for Zyla Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Mexico | 337619 | ⤷ Start Trial |
| Denmark | 2421525 | ⤷ Start Trial |
| South Korea | 20150018647 | ⤷ Start Trial |
| South Korea | 101580656 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Zyla Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1685839 | 92292 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
